Cosentyx (secukinumab) is a medication used to treat various inflammatory diseases, including psoriasis and psoriatic arthritis. The recommended dosage of Cosentyx varies depending on the condition being treated, the patient's age, weight, and medical history [3]. However, there is limited information available on whether the dosage of Cosentyx should differ for elderly patients.

According to the drug patent watch website, the recommended dosage of Cosentyx is the same for all adult patients, regardless of age [1]. However, a study published in the National Library of Medicine suggests that age may play a role in the efficacy of Cosentyx [2]. The study found that older patients with psoriasis may require higher doses of Cosentyx to achieve the same level of disease control as younger patients.

The prescribing information provided by Novartis, the manufacturer of Cosentyx, does not provide specific dosage recommendations for elderly patients [3]. However, the information does caution that elderly patients may be more susceptible to infections and should be monitored closely while taking Cosentyx.

In conclusion, while there is no specific dosage recommendation for elderly patients taking Cosentyx, age may play a role in the medication's efficacy. Patients should consult with their healthcare provider to determine the appropriate dosage based on their individual medical history and condition.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847154/
[3] https://www.novartis.com/us-en/sites/novartis_us/files/cosentyx.pdf